Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00238628
Recruitment Status : Completed
First Posted : October 13, 2005
Last Update Posted : July 20, 2010
Sponsor:
Collaborators:
Ligand Pharmaceuticals
AstraZeneca
Information provided by:
Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2005
  Actual Study Completion Date : December 2005